The Institute is geared towards the strategy of "Healthy China", led by Prof. Dong Chen, an internationally renowned immunologist and academician of the Chinese Academy of Sciences, and relying on the Shanghai Jiao Tong University School of Medicine and its affiliated Renji Hospital for systematic construction.
The Institute focuses on the research and development of tumor immunotherapy, chronic inflammatory diseases and transplantation immunity, infectious diseases and vaccines, and is committed to becoming a globally influential source of immunological innovations, an attraction base for high-end and key talents in the field of immunology, and a first-class base for the translation of basic immunological innovations into industrial applications.
In order to meet the needs of the Institute's scientific research development, in accordance with the principles of openness, equality, competition, and meritocracy, we are now recruiting researchers for our research groups.
I. Basic Requirements for Recruitment Positions
1. Love the Party, love the motherland, abide by the Constitution of the People's Republic of China and relevant laws and regulations, adhere to the spirit of science, strictly abide by the integrity of scientific research.
2. Love of scientific research, physical and mental health, strong sense of responsibility; good teamwork spirit and communication skills; good reading and writing skills in English and Chinese.
3. Biomedical and other related majors, with immunology research background is preferred (see the job postings, number and requirements for specific job requirements).
II. Recruitment positions, number and requirements
Recruitment positions and number: 13 associate researchers, 3 assistant researchers, 7 research assistants.
The details are as follows:
Subject Groups
Recruitment Positions
Degree Requirements
Specialties and Other Requirements
Delivery Email
Professor Ru Linrong's group of associate researcher 2 Ph.D.
2. Have certain research leadership ability, able to lead the group to carry out research; research direction or research interest fits with the research direction of the group.
3. Under the guidance of the subject group leader, to teach graduate students and carry out relatively independent research; to assist the subject group leader or independently apply for various types of scientific research projects.
linrong_lu@hotmail.com/lili7583@renji.comLai Guan Ng Research Associate 2 Ph.D. 1. Medical or biology related majors, preferably with a background in bioinformatics or neurobiology; 2. Assisting the group leader or independently applying for projects that fit the group's research direction. The researchers will be responsible for the development and implementation of the research projects in the group.
nglaiguan@renji.com科研助理2名硕士/学士1.生物学或者医学专业背景者优先; 2. Responsible for laboratory operation and administration related work; assist in conducting research and assist in daily experiments.
3. Relevant laboratory work experience is preferred, and administrative/financial related experience is preferred.
Associate researcher in researcher Yi Zhong's group 1 PhD Immunology, cell biology, epigenetics, oncology and other biomedical related majors; immunology research experience is preferred.
yi.zhong@shsmu.edu.cn陈硕研究员课题组副研究员2名博士1.负责团队结构生物学 (cryo-electron microscopy-based)/computational biology (deep learning-based) direction of scientific research; with a PhD degree in a related field; 2. Design and conduct scientific research under the guidance of the subject group leader, and assist in the construction of experimental platforms for the subject group; 3. Independently and participates in scientific research project applications; assists in mentoring and training of assistant researchers, postdoctoral fellows, and graduate students.
chenshuo@renji.com助理研究员2名博士1.协助团队结构生物学 (cryo-electron microscopy-based)/computational biology (deep learning-based) direction of scientific research, with a doctoral degree in related fields; 2. Design and conduct scientific research under the guidance of the group leader, and assist in the construction of the group's experimental platform; 3. Independently and participate in the application of scientific research projects; assist in the guidance and training of postdoctoral fellows and graduate students. Application; assist in the guidance and training of postdoctoral and graduate students.
Scientific Research Assistant 2 M.S./B.S.B.A. 1. Assisting in the construction of experimental platforms for subject groups; 2. Assisting in the application of scientific research projects; 3. Assisting in the management of subject groups.
Fu Guotong Research Associate, Computational Biology/Bioinformatics Analyst 2 Ph.D./M.S. 1.Ph.D. or M.S. degree in biomedical related fields or bioinformatics/computer related fields, with immunology related research background preferred.
2. Be able to independently carry out experimental or computational work that fits with the research direction of the group.
guotong.fu@shsmu.edu.cn科研助理1名硕士1.生物医学相关专业者优先; Proficiency in flow-through techniques and experience in animal experiments are preferred; 2. Stable work for at least two years is required; Participation in research projects according to individual wishes and team needs.
Wu Fan researcher group associate researcher 1 PhD 1. Biology or basic medicine related majors, immunology, virology, bioinformatics and other background is preferred; 2. Have the ability to carry out independent scientific research work.
wufan@renji.com周磊研究员课题组副研究员/助理研究员2名博士1.生物学或基础医学相关专业 background in immunology, neurobiology, tumor immunity or computational biology is preferred; 2. Ability to carry out scientific research independently.
zhoulei@renji.com刘志研究员课题组副研究员2名博士1.生物学或基础医学相关专业 solid foundation in immunology, bioinformatics, neurobiology, or tumor immunity background is preferred; 2. Ability to carry out scientific research independently; 3. Strong interest in scientific research and ability to assist or independently apply for scientific research projects .
liuzhi160703@sina.com科研助理2名学士及以上1.生物学, Pharmaceutical Sciences related majors.
2. Familiar with routine biological experimental operations (such as PCR, flow cytometry, immunohistochemistry, etc.), as well as experience in animal experiments is preferred; 3. Relevant laboratory work experience is preferred.
4. Responsible for laboratory operation and administration related work; assist in conducting research on topics, assist in daily experiments and data analysis.
Third, the group
Dong Chen Academician Group
Professor Dong Chen is an academician of the Chinese Academy of Sciences.
He is one of the founders and international authorities in the field of research related to the differentiation, regulation and function of Th17 cells, and has also made pioneering contributions to the discovery and study of Tfh and Tfr cells.
Professor Dong Chen's group is dedicated to immunology research, focusing on the molecular regulatory mechanisms of T-cell-related immune tolerance and immune response, as well as in-depth investigations of novel tumor immunotherapies in autoimmune diseases, inflammation, and tumors.
Professor Lu Linrong's group
Professor Lu Linrong is a National Ten Thousand People Plan Leader and National Outstanding Young Person.
The ICS (Immune Cell Signaling) group led by Prof. Lu focuses on signaling and regulatory mechanisms during T cell development and differentiation.
The laboratory focuses on the pathogenesis of autoimmune inflammation and autoimmune diseases, as well as the role of immune effects and regulatory mechanisms in anti-viral and anti-tumor immune responses.
Lai Guan Ng's group
Ng Lai Guan is a Senior Investigator and Director of the Center for Systemic Immunity Research at Renji Hospital, Shanghai Institute of Immunotherapy Innovation, Shanghai Jiao Tong University School of Medicine.
Ng Lai Guan is a Senior Investigator of the Center for Systemic Immunity Research, Shanghai Institute for Immunotherapy Innovation, Shanghai Jiao Tong University School of Medicine.
In technological innovation and development, we have developed and optimized microscopic imaging techniques such as in vivo multiphoton and 3D holistic imaging of organs.
Published more than 60 SCI articles in international journals during the period from 2015 to 2023, of which more than 20 are corresponding author/***same corresponding author articles.
According to google scholar statistics, the total citations of the articles are more than 15,000, with an h-index of 60; and in 2020 and 2023, we will be recognized as a "Highly Cited Scientist" in the global field for two consecutive years (Highly Cited Researcher). The Laboratory has been recognized as a "Highly Cited Scientist" in the global field for two consecutive years in 2020 and 2023.)
The laboratory's main research interests are the function and mechanism of myeloid cells in homeostasis and pathology, the development of neutrophil-based biomarkers and therapeutic targets, and the development and optimization of high-throughput dynamic microimaging techniques.
Specific research interests include (but are not limited to) the following areas: Direction 1: Neutrophil differentiation profiling; Direction 2: Heterogeneity of tumor neutrophils; Direction 3: Heterogeneity and functional reprogramming of myeloid immune cells in the setting of obesity and type 2 diabetes mellitus; Direction 4: Development of high-throughput microimaging techniques and their application in immunology.
Researcher Yi Zhong's Group
Researcher Yi Zhong, Ph.
Doctoral degree in bioinformatics from the University of Tübingen, Germany, in 2016.
Was awarded the EU Marie Curie Scholar Award at the doctoral level.
Later, she did postdoctoral research in immunology at Memorial Sloan-Kettering Cancer Center/HHMIRudensky Fellowship Laboratory, USA.
In 2023, he joined Renji Hospital, Shanghai Jiao Tong University School of Medicine as a Talent Introduction route to conduct research in systems immunology and computational biology.
Successively published several research papers in Nature Immunology (2022), Immunity (2019, 2020), CellResearch (2010, 2011) and Bioinformatics (2017) as the first and corresponding authors (including *** same).
The team's subject research is characterized by the intersection of disciplines, integrating cell biology, computational biology, epigenetics, single-cell sequencing technology and other strategies to study immunological problems.
For more information, please visit our homepage: zhong-lab.com.
The group covers the following research directions: quantitative epigenetic regulation of cell subpopulation dynamics during T cell differentiation and long-term memory formation; construction of regulatory maps of spatiotemporal development of T cells and molecular etiology of the development of related clinical diseases; reconfiguration of the multilayer transcriptional network of immune cells and prediction of cell fate models; and development of a model of cell fate prediction. Reconstruction of multilevel transcriptional regulatory network of immune cells and establishment of cell fate prediction model.
Shuo Chen's group
Shuo Chen received his undergraduate degree in Biological Sciences from the School of Life Sciences, Fudan University, and received his PhD degree in Clinical Medicine from Oxford University School of Medicine, where he studied the structural biology of tumor signaling and viruses under the tutelage of Royal Society Fellows Yvonne Jones and Dave Stuart.
Since then, he has been engaged in tumor suppression research in the laboratory of Yvonne Jones and at the Ludwig Institute, Oxford University, under the supervision of Royal Society Fellow Xin Lu.
He has now returned to China to join the Institute as the Medical Structural Biology Group Leader.
Relying on Renji Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunotherapy Innovation, and Shanghai Cancer Institute, the group takes structural biology as an entry point, focuses on the roles and mechanisms of key molecular hubs in major human diseases such as cancers and virus-induced infectious diseases, and is y engaged in the precision medicine targeting the mechanisms of the roles of these molecules, and discovers and creates drugs, constructs nano-machines, and builds tumor suppressors through artificial intelligence, protein engineering, and other methods. Through artificial intelligence, protein engineering and other methods, we will create drugs, build nano-machines and molecular factories, thus contributing to the construction of "Healthy China" and the promotion of human health.
Fu Guotong's group
Fu Guotong received his Ph.D. degree from Zhejiang University in 2017, and then carried out postdoctoral work at St. Jude Children's Research Hospital in the United States.
He joined SITI in January 2022, and his research interests are humoral immunity and tumor immunity.
In the past five years, she has published academic papers as the first author in journals such as Nature and JEM, as well as several academic papers as a *** co-author.
The laboratory is making full use of mouse models, immunological methods, systems biology (e.g., CRISPR screening and single-cell sequencing, etc.) and computational biology to reveal the regulatory mechanisms of humoral and tumor immunity.
E.g. 1. Tfh cell development; 2. Metabolism in tumor immunity; 3. CRISPR screening to study humoral response.
Researcher Fan Wu's group
Researcher Fan Wu focuses on Immunopathogenesis, neutralizing antibodies and vaccines for major infectious viral diseases.
Wu Fan has published more than 40 SCI papers in international top academic journals, including Nature, JAMA Internal Med, J Clin Invest, Cell Research, Cell Discovery, etc., with more than 10,000 citations (google citation), and has been consecutively selected as one of the "China's best researchers" by Elsevier ( Elsevier) "China's highly cited scholars" (see personal Google Scholar homepage citations?user=aJxlxP0AAAAJ).
Researcher Lei Zhou's group
Researcher Lei Zhou received his B.S. degree from Northwest Agriculture and Forestry University in 2011, and Ph.D. degree in biochemistry and molecular biology from East China Normal University in 2016, and carried out his postdoctoral research at Cornell University Medical College, U.S.A., from 2016-2023, and was appointed as a researcher of Shanghai Institute of Immunotherapy Innovation in 2022. researcher with research interests in mucosal immunology and neuroimmunology.
In the past five years, she has published research papers in Nature and Nature Immunology (****same as corresponding author) as the first author, and has published review articles in Immunity and Science Immunology as the first author, for details, please refer to her personal Google Scholar Citations For more information, please see your Google Scholar Citations page (citations?user=u5PBXYsAAAAJ).
The group will utilize mouse animal models and clinical patient samples, combined with high-throughput screening and computational biology methods to (i) reveal the functions and mechanisms of intrinsic lymphocytes in homeostasis, inflammation, and cancer in the body, and (ii) explore the interactions among the intestinal flora, immune system, and enteric nervous system.
Researcher Liu Zhi's group
Liu Zhi, received his PhD degree from the Shanghai Institutes for Life Sciences, Chinese Academy of Sciences in 2016, and worked as a postdoctoral researcher at the Salk Institute for Biological Studies in the United States from 2016-2022, where he received the Melvin Cohn Award, and joined the Renji Hospital of Shanghai Jiao Tong University School of Medicine/Shanghai Immunotherapy Innovation Research Institute.
Successively published academic papers as the first author in NatureImmunology, CellDeath&Differentiation, JMolCellBiol, etc., and published several important research papers as ****same author.
This group focuses on the heterogeneity and functional diversity of tissue T cells, and comprehensively utilizes genetic mutant mice, disease models, single-cell sequencing technology, and clinical samples to carry out the following studies: 1. the regulatory mechanism of tissue-specific function of regulatory T cells; 2. the molecular mechanism of immune cells to promote tissue repair and regeneration; 3. the molecular mechanism of immune cells to promote tissue repair and regeneration; and 4. the molecular mechanism of immune cells to promote tissue repair and regeneration; 5. the molecular mechanism of immune cells to promote tissue repair and regeneration. The molecular mechanism of immune cells to promote tissue repair and regeneration; 3. Tissue T cells in the body of aging, autoimmunity and cancer in the dynamic changes and role of the mechanism.
Fourth, the way to apply
1. Please send your resume (including education and scientific research experience, publications, awards and major research skills, etc.) and supporting materials, such as certificates of academic qualifications and degrees, in PDF file format to the corresponding e-mail address; the name of the e-mail should be "** subject group Apply for the post Name "
2. Applicants for the positions of Associate Researcher and Assistant Researcher should also provide the following application materials: letters of recommendation and contact information from two peer experts, and other materials that can illustrate the scientific research and work ability;
3. The recruitment announcement will be valid until December 31, 2023, while supplies last.
V. Treatment
1. Competitive salary (negotiable) and favorable research environment; support career development according to individual interests and needs.
2. Benefits related to Renji Hospital, Shanghai Jiao Tong University School of Medicine, including five insurance and two pensions, paid annual leave.
6. Recruitment Procedures
1. We will conduct preliminary selection and qualification examination based on the application materials, and determine the candidates for interviews, which will be organized by the Institute for interviews with experts inside and outside of the hospital, to determine the candidates to be recruited.
After passing the interview of the institute, we will determine the employment.
Application materials will not be returned, the recruiter will be kept confidential.
2. Physical examination: with reference to the "National Civil Servants General Physical Examination Standards (Trial)", the current three hospitals to pass the physical examination.
3. Examination: organized by the hospital inspection, mainly to examine the candidates' ideological and political quality, compliance with the law and integrity records.
Based on the results of the assessment, physical examination, inspection, the proposed employment in the Shanghai Municipal Bureau of Human Resources and Social Security network for publicity, publicity time of 7 days, publicity without objection to the Shanghai Municipal Bureau of Human Resources and Social Security approved for the record, publicity, if there are objections to the impact of the employment of the results of the investigation, according to the results of the verification of the confirmation of whether or not to hire.
Seven, contact:
Contact: Ms. Yu
Contact phone: 13004178748
Renji Hospital, Shanghai Jiao Tong University School of Medicine
2023/02/27
Self-examination / Chengdu examination have questions, do not know the content of the self-examination / Chengdu examination points, not clear local self-examination / Chengdu examination policy, click on the bottom to consult the official website teacher, free review materials:/xl/